Leichman CG - Search Results

1

Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial.

Moinpour CM, Sawyers Triplett J, McKnight B, Lovato LC, Upchurch C, Leichman CG, Muggia FM, Tanaka L, James WA, Lennard M, Meyskens FL Jr. Moinpour CM, et al. Among authors: leichman cg. Psychooncology. 2000 Jul-Aug;9(4):340-54. doi: 10.1002/1099-1611(200007/08)9:4<340::aid-pon466>3.0.co;2-f. Psychooncology. 2000. PMID: 10960931 Clinical Trial.

2

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.

Leichman CG, Fleming TR, Muggia FM, Tangen CM, Ardalan B, Doroshow JH, Meyers FJ, Holcombe RF, Weiss GR, Mangalik A, et al. Leichman CG, et al. J Clin Oncol. 1995 Jun;13(6):1303-11. doi: 10.1200/JCO.1995.13.6.1303. J Clin Oncol. 1995. PMID: 7751875 Clinical Trial.

3

A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer.

Saltz LB, Leichman CG, Young CW, Muggia FM, Conti JA, Spiess T, Jeffers S, Leichman LP. Saltz LB, et al. Among authors: leichman cg, leichman lp. Cancer. 1995 Feb 1;75(3):782-5. doi: 10.1002/1097-0142(19950201)75:3<782::aid-cncr2820750306>3.0.co;2-i. Cancer. 1995. PMID: 7828128 Clinical Trial.

4

Biological modification of protracted infusion of 5-fluorouracil with weekly leucovorin. A dose seeking clinical trial for patients with disseminated gastrointestinal cancers.

Leichman CG, Leichman L, Spears CP, Rosen PJ, Muggia F, Jeffers S, Waugh W. Leichman CG, et al. Among authors: leichman l. Cancer Chemother Pharmacol. 1990;26(1):57-61. doi: 10.1007/BF02940295. Cancer Chemother Pharmacol. 1990. PMID: 2182214 Clinical Trial.

5

Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.

Muggia FM, Wu X, Spicer D, Groshen S, Jeffers S, Leichman CG, Leichman L, Chan KK. Muggia FM, et al. Among authors: leichman cg, leichman l. Clin Cancer Res. 1996 Sep;2(9):1461-7. Clin Cancer Res. 1996. PMID: 9816321 Clinical Trial.

6

Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study.

Israel VK, Jiang C, Muggia FM, Tulpule A, Jeffers S, Leichman L, Morrow CP, Roman L, Leichman CG, Chan KK. Israel VK, et al. Among authors: leichman cg, leichman l. Cancer Chemother Pharmacol. 1995;37(1-2):32-8. doi: 10.1007/BF00685626. Cancer Chemother Pharmacol. 1995. PMID: 7497594 Clinical Trial.

7

Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program.

Leichman L, Silberman H, Leichman CG, Spears CP, Ray M, Muggia FM, Kiyabu M, Radin R, Laine L, Stain S, et al. Leichman L, et al. Among authors: leichman cg. J Clin Oncol. 1992 Dec;10(12):1933-42. doi: 10.1200/JCO.1992.10.12.1933. J Clin Oncol. 1992. PMID: 1453207 Clinical Trial.

8

Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis.

Ray MS, Muggia FM, Leichman CG, Grunberg SM, Nelson RL, Dyke RW, Moran RG. Ray MS, et al. Among authors: leichman cg. J Natl Cancer Inst. 1993 Jul 21;85(14):1154-9. doi: 10.1093/jnci/85.14.1154. J Natl Cancer Inst. 1993. PMID: 8320744 Clinical Trial.

9

Intraperitoneal 5-fluoro-2'-deoxyuridine with escalating doses of leucovorin: pharmacology and clinical tolerance.

Muggia FM, Tulpule A, Retzios A, Chen F, Jeffers S, Leichman CG, Leichman L, Spears CP, Chan KK. Muggia FM, et al. Among authors: leichman cg, leichman l. Invest New Drugs. 1994;12(3):197-206. doi: 10.1007/BF00873960. Invest New Drugs. 1994. PMID: 7896538 Clinical Trial.

10

Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors.

Koda RT, Garcia AA, Chatterjee DJ, Li WY, Parimoo D, Jeffers S, Rogers M, Leichman CG, Leichman L, Wu EY, Shetty BV, Webber S, Clendinnin N, Muggia FM. Koda RT, et al. Among authors: leichman cg, leichman l. Cancer Chemother Pharmacol. 1999;43(6):489-96. doi: 10.1007/s002800050928. Cancer Chemother Pharmacol. 1999. PMID: 10321509 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters